Medistim ASA (MEDI) — Net Asset Quality Index
Medistim ASA (MEDI) has a Net Asset Quality Index of 71.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Nkr535.04 Million minus total liabilities of Nkr151.23 Million yields net assets of Nkr383.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Medistim ASA balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medistim ASA Net Asset Quality Index Over Time (2004–2024)
This chart shows how Medistim ASA's Net Asset Quality Index has evolved across 21 annual periods from 2004 to 2024. As of June 2025, the index stands at 71.7%, representing net assets of Nkr383.81 Million against total assets of Nkr535.04 Million NOK. For live market cap and overall valuation, see MEDI market cap overview.
Annual Net Asset Quality Index for Medistim ASA (2004–2024)
The table below presents the year-by-year Net Asset Quality Index for Medistim ASA from 2004 to 2024, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Medistim ASA to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (NOK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 75.9% | Nkr436.61 Million | Nkr574.97 Million | Nkr138.36 Million | ▼ -2.8 pp |
| 2023 | 78.7% | Nkr397.94 Million | Nkr505.72 Million | Nkr107.78 Million | ▲ +2.5 pp |
| 2022 | 76.2% | Nkr367.69 Million | Nkr482.66 Million | Nkr114.97 Million | ▲ +0.3 pp |
| 2021 | 75.9% | Nkr306.05 Million | Nkr403.24 Million | Nkr97.19 Million | ▲ +1.6 pp |
| 2020 | 74.3% | Nkr256.85 Million | Nkr345.82 Million | Nkr88.97 Million | ▲ +3.8 pp |
| 2019 | 70.5% | Nkr236.86 Million | Nkr336.11 Million | Nkr99.25 Million | ▼ -6.2 pp |
| 2018 | 76.7% | Nkr206.71 Million | Nkr269.59 Million | Nkr62.88 Million | ▲ +3.8 pp |
| 2017 | 72.9% | Nkr182.98 Million | Nkr251.06 Million | Nkr68.08 Million | ▼ -3.9 pp |
| 2016 | 76.8% | Nkr166.70 Million | Nkr217.05 Million | Nkr50.34 Million | ▲ +5.3 pp |
| 2015 | 71.5% | Nkr156.16 Million | Nkr218.44 Million | Nkr62.27 Million | ▲ +3.1 pp |
| 2014 | 68.4% | Nkr139.10 Million | Nkr203.49 Million | Nkr64.39 Million | ▼ -3.9 pp |
| 2013 | 72.2% | Nkr121.64 Million | Nkr168.39 Million | Nkr46.76 Million | ▼ -3.6 pp |
| 2012 | 75.8% | Nkr115.17 Million | Nkr151.87 Million | Nkr36.70 Million | ▲ +4.4 pp |
| 2011 | 71.4% | Nkr106.89 Million | Nkr149.63 Million | Nkr42.74 Million | ▼ -2.5 pp |
| 2010 | 73.9% | Nkr107.83 Million | Nkr145.94 Million | Nkr38.11 Million | ▲ +0.9 pp |
| 2009 | 73.0% | Nkr106.29 Million | Nkr145.63 Million | Nkr39.33 Million | ▲ +7.3 pp |
| 2008 | 65.7% | Nkr95.46 Million | Nkr145.38 Million | Nkr49.92 Million | ▼ -7.2 pp |
| 2007 | 72.9% | Nkr93.83 Million | Nkr128.79 Million | Nkr34.96 Million | ▲ +10.7 pp |
| 2006 | 62.2% | Nkr74.06 Million | Nkr119.15 Million | Nkr45.09 Million | ▼ -17.2 pp |
| 2005 | 79.3% | Nkr67.41 Million | Nkr85.00 Million | Nkr17.58 Million | ▼ -3.9 pp |
| 2004 | 83.2% | Nkr61.71 Million | Nkr74.19 Million | Nkr12.47 Million | — |